News
Stay up to date on topics that are important to Nurse Practitioners.
-
Carbidopa/Levodopa Fractional Tablet Now Available for Parkinson’s Disease
A carbidopa/levodopa tablet formulation (Dhivy) designed to facilitate dose adjustment is now available for the treatment of Parkinson’s…
-
FDA Approves Treatment for Wider Range of Patients With Heart Failure
The FDA approved empagliflozin (Jardiance) to reduce the risk of cardiovascular death and hospitalization for heart failure in…
-
New Migraine Treatment Approved in Adults
Celecoxib oral solution (Elyxyb) was approved for the acute treatment of migraine with or without aura in adults.…
-
CDC Advises Moderately or Severely Immunocompromised Teens, Adults to Get Fourth COVID-19 Shot
The Centers for Disease Control and Prevention (CDC) advised that moderately or severely immunocompromised teens and adults receive…
-
New-Onset Bladder Symptoms in Discharged COVID Patients
Men and women who have been hospitalized with COVID-19 have reported new-onset severe genitourinary symptoms, including increased frequency,…
-
FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to Omicron Variant
The FDA revised the authorization for two monoclonal antibody treatments, bamlanivimab and etesevimab (administered together) and REGEN-COV (casirivimab…
-
FDA Approves Remdesivir (Veklury) for Outpatient COVID-19 Treatment
The FDA has expanded the approved use of remdesivir (Veklury) to certain non-hospitalized adults and pediatric patients for…
-
FDA Formally Approves Moderna’s COVID-19 Vaccine
The FDA formally approved the second COVID-19 vaccine, Moderna’s COVID-19 vaccine, which will be marketed as Spikevax. Spikevax…
-
First Generic of Cyclosporine Ophthalmic Emulsion Eye Drops (Restasis) Approved for Dry Eye
The FDA approved the first generic version of cyclosporine ophthalmic emulsion 0.05% single-use vials (Restasis) to increase tear…
-
CDC Issues Simplified New Recommendations for Pneumococcal Vaccination in Adults
Updated pneumococcal vaccine recommendations for adults were issued by the Centers for Disease Control and Prevention, calling for…
-
Rivaroxaban (Xarelto) Approved for Pediatric Indication to Help Prevent, Treat Clots
The FDA approved two new pediatric indications for rivaroxaban (Xarelto), a factor Xa anticoagulant with multiple indications in…
-
New Medication Spray Approved for Seasonal Allergic Rhinitis
The FDA approved olopatadine hydrochloride/mometasone furoate (Ryaltris) nasal spray, a combination histamine-1(H1)-receptor inhibitor/corticosteroid, for the treatment of symptoms…
Trending
Join our email list
Get new course alerts, newsletters and more delivered directly to your inbox
By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.